J. S. Wefel

RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).

M. R. Gilbert, M. Wang, Kenneth Aldape et al. · Journal of Clinical Oncology · 2011 · 119 citations

Medicine, Oncology, Pharmacology +17

Course of Cognitive Decline in Hematopoietic Stem Cell Transplantation: A Within-subjects Design

Marvin A. Friedman, M. Isabel Fernández, J. S. Wefel et al. · Archives of Clinical Neuropsychology · 2009 · 50 citations · Full text

Medicine, Hematology, Psychology +17

Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving Whole-brain Radiation Therapy (WBRT): First Report of RTOG 0614, a Placebo-controlled, Double-blind, Randomized Trial

P.D. Brown, Stephanie Shook, Nadia N. Laack et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 32 citations · Full text

Medicine, Neuroscience, Radiation Oncology +17

Dual Immune Check Point Blockade in <i>MGMT</i> -Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial

Andrew B. Lassman, Mei‐Yin C. Polley, Fábio M. Iwamoto et al. · Journal of Clinical Oncology · 2025 · 22 citations · Full text

Medicine, Immunology, Oncology +17

Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)

Vinai Gondi, S. Pugh, Minesh P. Mehta et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 19 citations

Medicine, Oncology, Radiation Oncology +11